NDC 68788-8811
Levothyroxine Sodium 175 ug tablet
On the label: Preferred Pharmaceuticals, Inc... It's repackaged: Preferred Pharmaceuticals, Inc.. rebottles it from Macleods Pharmaceuticals Limited's NDC 33342-402.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | Valsad, India | Makes it, makes the active ingredient, tests it, packages it, labels it and mills it | Problems found, fixed voluntarilyAug 4, 2026 · 5 inspections |
Repackaging site
- Preferred Pharmaceuticals Inc., Anaheim, CA, United States · repackages it
Recalls
- Feb 26, 2026 · Class II · Macleods Pharma Usa, Inc
Subpotent Drug
Lots: Lot 16240062A, exp date 3/2026 - May 29, 2025 · Class III · Macleods Pharmaceuticals Ltd
Presence of a foreign substance: black hair found embedded in tablet.
Lots: Lot #: MLF2401A, Exp 01/31/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 175 ug
- Approval
- ANDA ANDA211417
- On the market since
- Jan 20, 2025
- Package NDCs
68788-8811-168788-8811-368788-8811-668788-8811-9- Official label
- DailyMed (National Library of Medicine), updated Jan 20, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?